TRAW
Traws Pharma, Inc. · Healthcare
Insiders bought $998K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Apr 29, 2026
Insider Buying
$998K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Apr 29, 2026
ORBIMED ADVISORS LLC
Traws Pharma, Inc. (TRAW) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 29, 2026.
Inside the rolling window, 1 insider at Traws Pharma, Inc. reported 1 open-market purchase totaling $998K and no open-market sales. Insiders have net bought $998K over the trailing 6 months. The most recent open-market filing is a purchase of 597,729 shares by 10% Owner ORBIMED ADVISORS LLC, dated Apr 16, 2026, worth $998K.
- Industry:Biotechnology
- CEO:Iain D. Dukes
- Employees:7
- HQ:Newtown, PA, US
- IPO:2013-07-25
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 597,729 | $998K | Apr 29 | -60.0% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TRAW have?
Traws Pharma, Inc. (TRAW) has 11 SEC Form 4 filings (11 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Apr 29, 2026.
When was the most recent SEC Form 4 filing for TRAW?
The most recent Form 4 filing for TRAW on Tracefour is dated Apr 29, 2026.
What is the net insider flow at TRAW over the last 6 months?
Over the trailing 180 days, insiders at TRAW have net bought $998K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TRAW in the current window?
Inside the rolling window, insiders at TRAW bought $998K and sold $0 based on SEC Form 4 filings.
Can I get alerts for TRAW insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Traws Pharma, Inc. (TRAW). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Traws Pharma, Inc. is in the Healthcare sector.